Blueprint Medicines Corp (NAS:BPMC)
$ 96.53 -1.09 (-1.12%) Market Cap: 6.13 Bil Enterprise Value: 5.94 Bil PE Ratio: 0 PB Ratio: 19.54 GF Score: 81/100

Blueprint Medicines Corp at JMP Securities Life Sciences Conference (Virtual) Transcript

Jun 16, 2022 / 04:30PM GMT
Release Date Price: $46.78 (-2.48%)
Reni Benjamin
JMP Securities LLC - Analyst

Excellent. So good afternoon, everyone. It's my distinct pleasure to introduce Blueprint Medicines Corporation, commercial-stage company with some really important milestone drivers coming up later this year that can expand their opportunity significantly.

Joining us virtually is Christy Rossi, COO; and Percy Carter, CSO. As you guys know, the format that I like is to kind of start off with a little bit of an overview for those of you in the audience who might not know Blueprint. If you can maybe spend two to five minutes there, Christy, just introducing the company before we jump into some specific questions.

Christy Rossi
Blueprint Medicines Corporation - COO

So happy to. First, I wanted to thank you, Ren, for having us and the whole JMP team, and also for your flexibility today. We had intended to be there in person. We have to do a little bit of a switch to virtual. I think we're probably not the only people who are impacted by some of the weather issues in New York this morning. So thank you for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot